During the recent Heart Rhythm 2014 event, three different studies were presented to demonstrate accuracy of the AliveCor Heart Monitor.
AliveCor Heart Monitor can generate accurate tracings in the remote setting in the pediatric population.First one is the iTransmit Study, “Evaluating the Efficacy and Feasibility of a Novel Wireless Recording System Using Smartphone in Monitoring Patients After Atrial Fibrillation Ablation Procedure,” which was led and presented by Dr. Khaldoun G. Tarakji of Cleveland Clinic. Dr. Tarakji and his team found that the AliveCor Heart Monitor had 100% sensitivity and 95% specificity at detecting atrial fibrillation (AF) after an ablation procedure compared to a standard transtelephonic event monitor. The study involved 38 patients with diagnosed AF undergoing pulmonary vein isolation.
Second study, the SPEAR TRIAL – “Smartphone Pediatric Electrocardiogram Trial,” was presented by Dr. Hoang Nguyen with Senior Author Dr. Jennifer Silva from Washington University in St. Louis, Missouri. The trial included 30 patients with potential and diagnosed arrhythmias, with preliminary data demonstrating that the AliveCor Heart Monitor can generate accurate tracings in the remote setting in the pediatric population. Additionally, the study found that both patients and parents love AliveCor’s device — 95% indicated it was easy to use and 95% prefer to continue using the device once the study ends.
The AliveCor Heart Monitor demonstrated a sensitivity and specificity for the detection of AF/atrial flutter of 94.4% and 99.3%, respectively.Finally, the third study, “Wireless Smart Phone Equipped ECG Enables Large Scale Screening in Diverse Populations,” presented by Dr. Zach Haberman with Senior Author Dr. Leslie Saxon at the University of California Irvine, Orange, California and the USC Keck School of Medicine, compared the AliveCor Heart Monitor with a 12-lead ECG in detecting AF and other cardiac abnormalities. The AliveCor Heart Monitor demonstrated a sensitivity and specificity for the detection of AF/atrial flutter of 94.4% and 99.3%, respectively. 382 subjects participated in the study, including USC Division 1 athletes, healthy young adults and electrophysiology clinic patients.
The AliveCor Heart Monitor is the only FDA cleared mobile ECG recorder that supports both iPhone and Android mobile devices. It can record, display, store, and transfer single-channel ECG rhythms wirelessly, using the free AliveECG app.